Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACHIEVE Trial
NCT03020303Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Jul 2017
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of spironolactone in end stage renal disease (ESRD), sponsored by Hamilton Health Sciences. Started Jul 2017; status: completed.
02
Drugs
spironolactone
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT03020303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020303.